Z.M. Younossi

1.1k total citations · 1 hit paper
10 papers, 743 citations indexed

About

Z.M. Younossi is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Z.M. Younossi has authored 10 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Z.M. Younossi's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (3 papers) and Liver Diseases and Immunity (2 papers). Z.M. Younossi is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (3 papers) and Liver Diseases and Immunity (2 papers). Z.M. Younossi collaborates with scholars based in United States, Spain and France. Z.M. Younossi's co-authors include Giulio Marchesini, Yngve Falck–Ytter, Arthur J. McCullough, Andrew F. Pitts, Gerald M. Bordin, Andrea Duchini, Alan Saven, Helen J. Knowles, Vlad Ratziu and A. Sanyal and has published in prestigious journals such as Hepatology, Journal of Hepatology and Seminars in Liver Disease.

In The Last Decade

Z.M. Younossi

9 papers receiving 721 citations

Hit Papers

Clinical Features and Nat... 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Z.M. Younossi United States 6 649 297 297 142 121 10 743
Alessandra Marrazzo Italy 5 667 1.0× 301 1.0× 263 0.9× 123 0.9× 92 0.8× 8 796
D.M. Harnois United States 11 652 1.0× 315 1.1× 349 1.2× 112 0.8× 157 1.3× 56 783
Takenao Hasegawa Japan 6 517 0.8× 275 0.9× 268 0.9× 77 0.5× 118 1.0× 8 607
Tsubasa Tsutsumi Japan 13 741 1.1× 377 1.3× 285 1.0× 228 1.6× 109 0.9× 31 832
Mayada Metwally Australia 4 817 1.3× 334 1.1× 412 1.4× 150 1.1× 99 0.8× 6 883
Simonetta Lugari Italy 11 517 0.8× 326 1.1× 180 0.6× 84 0.6× 74 0.6× 14 601
JANE HOLMES-WALKER Australia 3 835 1.3× 506 1.7× 217 0.7× 151 1.1× 189 1.6× 7 958
Lui Li China 5 472 0.7× 292 1.0× 152 0.5× 178 1.3× 74 0.6× 8 557
Stephen Glancy United Kingdom 10 448 0.7× 237 0.8× 163 0.5× 82 0.6× 162 1.3× 21 576
Antonio Luis Eiras de Araújo Brazil 6 403 0.6× 223 0.8× 124 0.4× 88 0.6× 87 0.7× 10 465

Countries citing papers authored by Z.M. Younossi

Since Specialization
Citations

This map shows the geographic impact of Z.M. Younossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z.M. Younossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z.M. Younossi more than expected).

Fields of papers citing papers by Z.M. Younossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z.M. Younossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z.M. Younossi. The network helps show where Z.M. Younossi may publish in the future.

Co-authorship network of co-authors of Z.M. Younossi

This figure shows the co-authorship network connecting the top 25 collaborators of Z.M. Younossi. A scholar is included among the top collaborators of Z.M. Younossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z.M. Younossi. Z.M. Younossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Younossi, Z.M., Leyla de Avila, Andrei Racila, et al.. (2025). Prevalence and predictors of cirrhosis and portal hypertension in the United States. Hepatology. 82(5). 1229–1240. 5 indexed citations
2.
Takahashi, Akira, Kei Moriya, Teruko Arinaga‐Hino, et al.. (2018). Health-Related Quality of Life in patients with autoimmune hepatitis. Journal of Hepatology. 68. S233–S233.
3.
Ratziu, Vlad, A. Sanyal, Leigh MacConell, et al.. (2016). Regenerate: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Multicenter Study of Obeticholic Acid Therapy for Nonalcoholic Steatohepatitis. Journal of Hepatology. 64(2). S294–S295. 15 indexed citations
6.
Pitts, Andrew F., et al.. (2008). 6 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH HIGHER OVERALL MORTALITY AND LIVER RELATED MORTALITY. Journal of Hepatology. 48. S5–S5. 110 indexed citations
7.
Younossi, Z.M., et al.. (2006). Non-alcoholic fatty liver disease and hepatitis C infection.. PubMed. 52(2). 135–43. 38 indexed citations
8.
Falck–Ytter, Yngve, Z.M. Younossi, Giulio Marchesini, & Arthur J. McCullough. (2001). Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes. Seminars in Liver Disease. 21(1). 17–26. 522 indexed citations breakdown →
9.
Duchini, Andrea, et al.. (2000). An Open-label Pilot Trial of Cladibrine (2-Chlorodeoxyadenosine) in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Gastroenterology. 31(4). 292–296. 28 indexed citations
10.
Younossi, Z.M.. (2000). Viral hepatitis guide for practicing physicians. Cleveland Clinic Journal of Medicine. 67(Supplement_1). S1–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026